A Study of DA-302168S in Participants With Overweight/Obesity

NCT07629544 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

840

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight and Obesity

Interventions

DRUG: DA-302168S
DRUG: DA-302168S
DRUG: Placebo

Sponsor

Chendu DIAO Pharmaceutical Group CO., LTD.

Collaborators

[object Object]